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Mycobacterium tuberculosis Isolates
of Beijing Genotype in Thailand
To the Editor: Anh and colleagues recently reported that in
new tuberculosis (TB) cases from Vietnam, Mycobacterium
tuberculosis isolates of the Beijing genotype are associated
with younger age and, in isolates from Ho Chi Minh City,
with resistance against isoniazid and streptomycin (1).
However, occurrence of Beijing genotype M. tuberculosis
strains may be different in other Southeast Asian countries
such as Thailand.
From May 1999 to June 2000, we obtained 244
M. tuberculosis isolates from TB patients at Ramathibodi
Hospital, Bangkok, Thailand (the hospital treats approxi-
mately 625 TB patients annually). The isolates have been
prospectively analyzed by DNA-fingerprinting with the
spoligotyping method (2). Drug-resistance testing and
recording of patients’ data (sex, age, geographic origin)
were completed for 204 of 244 patients. The 204 patients
originated from all six regions of Thailand, although the
central region (comprising the Bangkok area) and the
northeast region predominated (59% and 23.5%, respective-
ly). Altogether 111 male and 93 female patients with a
median age of 34 years (1 to 89 years) were included. Status
of BCG vaccination or HIV infection was not assessed.
The Beijing genotype was found in 90 (44.1%) of the
204 isolates analyzed in detail, without significant differ-
ences regarding the respective patients’ geographic origin or
sex. Thus in Thailand, the frequency of the Beijing type is
somewhere between the frequency in Vietnam (53%) (1) and
in peninsular Malaysia (estimated at 24%) (3). Using the
same age groups as Anh and colleagues, we did not find an
association of Beijing genotype with young age (p = 0.41;
chi-square test for trend). Although Beijing type isolates
were more frequent among patients <25 years (18 [56%] of
32) than among those >25 years (69 [43%] of 161), this was
not significant (p = 0.13). This association remained not
significant, if only isolates from the central or the northeast
region were analyzed.
Of 204 isolates, 62 (30%) showed resistance to >1 of 4
drugs tested (isoniazid, 8.8%; rifampicin, 6.4%; streptomycin,
19.6%; ethambutol, 4.9%). However, overall drug resistance,
resistance to single drugs, and multidrug resistance were
not associated with the Beijing genotype. The frequency of
resistance was similar in distribution but overall lower
than reported for the Ho Chi Minh City isolates (isoniazid,
24%; rifampicin, 2%; streptomycin, 31%; ethambutol, 2%) (1).
In both studies, the highest percentage of drug resis-
tance was found for streptomycin. In our sample, this was
not associated with particular spoligotypes or with geo-
graphic origin of the patient. Furthermore, streptomycin-
resistant isolates were not more frequent in older age
groups, although there was a nonsignificant trend (p = 0.12;
chi-squaretrend). Streptomycin is still used for standard
quadritherapy in Thailand, and occurrence of resistant
strains can reflect selection or transmission recently or in
the past. This differs from occurrence of streptomycin
resistance in countries where streptomycin is no longer
used in standard therapy (4).
In the original description of the Beijing family of
strains in 1995, Beijing genotype isolates were found in 7
(37%) of 19 Thai isolates (5). In a subsequent IS6110
restriction fragment length polymorphism analysis, 80
(38%) of 211 isolates from central Thailand collected in
1994 to 1995 belonged to the Beijing family (6). Whether 90
(44%) of 204 among our recent isolates reflect a reliable
increase in Beijing type transmission over the last 5 years,
is difficult to state. However, the fact that no correlation of
Beijing type with (young) age of the patient was observed in
the previous analysis (6) supports the notion that increas-
ing incidence of the Beijing strain in Thai cases is not due
to recent transmission.
The M. tuberculosis population appears to be consider-
ably more heterogeneous in Thailand than in the large
urban areas of Vietnam. In our study, the three most
common spoligopatterns besides Beijing, S156, S153, and
S22 (according to the nomenclature of Soini et al. [7]),
together comprised 20% of 244 isolates. However, the
second most frequent spoligopattern, the “Vietnam geno-
type” (S10 according to Soini), reportedly shared by 27% of
the Vietnamese isolates, was not found in our sample ofLetters
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Thai isolates. Only 20 different spoligopatterns were found
among 499 isolates in the Vietnam study, compared to 60
among 244 isolates in our study.
Although the Beijing genotype of M. tuberculosis has been
recognized in settings of emerging drug resistance around the
world, the situation in Southeast Asian countries with a high
frequency of Beijing type isolates appears to be nonuniform.
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Jungle Yellow Fever, Rio de Janeiro
To the Editor: Yellow fever control in Brazil through
vaccination campaigns began in 1937. However, cases of
jungle yellow fever still occur despite the existence of a
potent vaccine and immunization campaigns focused on
areas endemic for the jungle form of the disease (1).
Most of these cases are in men in rural areas.
In Brazil from 1980 to 1998, 376 cases of jungle yellow
fever were laboratory confirmed (by virus isolation, with or
without immunoglobulin [Ig]M-capture enzyme-linked
immunosorbent assay [MAC-ELISA] and immunoperoxi-
dase stain), with 216 deaths (case-fatality rate 57.4%). Most
cases were from Maranhão and Goiás States, with 99 and
41 cases, respectively; Goiás, in midwestern Brazil, reported
a case-fatality rate of 95%.
During 1998 to 1999, 106 cases of jungle yellow fever were
confirmed, with 40 deaths (37.7%). During 1999, 75 cases
were confirmed, compared with 34 cases in 1998 and a mean
of 20 cases per year from 1980 to 1998 (2). In 2000, 84 cases
were confirmed, with 40 deaths (47.6% case-fatality rate).
During 2000, the probable site of infection for nearly all
cases was in Goiás, with 53 confirmed cases and 23 deaths,
suggesting epizootic circulation of the virus (2). These cases
were in unvaccinated persons who became ill in their home
states after traveling to endemic areas for tourism or work.
In Brazil, almost two thirds of the territory is consid-
ered an enzootic area (3). Rio de Janeiro State is not
endemic for jungle yellow fever, but in January 2000, the
Oswaldo Cruz Institute confirmed a case of yellow fever in a
24-year-old woman who had traveled to a national park in
Goiás State on December 28, 1999, with a group of 17 persons.
Yellow fever infections were also confirmed in tourists from
other states who visited this park in late 1999.
The young woman became ill on January 3 with fever,
headache, retroocular pain, prostration, anorexia, and
nausea. She returned to Rio de Janeiro on January 5 and
visited a private clinic on January 7, when a complete blood
count, platelet count, urea, creatinine, liver function tests,
and dengue serologic testing were performed. The patient
had leukopenia (1,730 leukocytes/mm3), 100,000 platelets/
mm3, AST 911 U/L and ALT 680 U/L, creatinine 0.90 mg/
dL, urea 10 mg/dL, and normal bilirubin and protein. Anti-
dengue IgM serology was negative. A blood sample was
collected January 11 for yellow fever diagnosis. Reverse
transcription-polymerase chain reaction (RT-PCR) test was
performed on RNA extracted from the serum (4), and virus
isolation was attempted on C6/36 cells, both with negative
results. A MAC-ELISA test was positive for yellow fever,
with a serum IgM titer 1/80,000 8 days after onset of
symptoms. The patient recovered within a week. After
confirmation of this case in the only person who became ill
in the travel group, yellow fever IgM serologic testing was
performed on the other group members, all of whom tested
negative. RT-PCR and virus isolation were not attempted
because the sera were taken after the viremia period.
Control measures for the Aedes aegypti vector were
promptly taken for a radius of 300 m around the patient’s
home. A vaccination campaign was carried out, during which
735 neighbors were vaccinated. An epidemiologic survey was
conducted in the area by using active surveillance for all
symptomatic cases of fever during the period of yellow fever
transmissibility. Blood samples from patients with fever
were assessed for yellow fever virus and antibodies. Surveil-
lance was intensified immediately in Rio de Janeiro State,
and our laboratory examined 54 sera from patients who had
traveled recently to endemic areas and who had compatible
signs and symptoms (in accordance with a nationwide
protocol). All these persons tested negative for yellow fever.
From January to July 2000, >16.9 million people were
vaccinated against yellow fever (2); however, cases continue
to occur. Unvaccinated persons who visit yellow fever-
endemic areas pose a high risk of introducing jungle yellow
fever cases into nonendemic areas.
Ana M.B. Filippis,* Hermann G. Schatzmayr,
* Cecília Nicolai,† Mary Baran,†
Marize P. Miagostovich,* Patrícia C. Sequeira,
* and Rita M.R. Nogueira*
*Oswaldo Cruz Institute, Oswaldo Cruz Foundation-FIOCRUZ,
Rio de Janeiro, Brazil; and †Municipal Health Department,
Rio de Janeiro, Brazil